The NHF-Baxter Clinical Fellowship Program

The National Hemophilia Foundation-Baxter Clinical Fellowship Program, funded through the generous support of Baxter Healthcare Corporation, is intended to increase the number of skilled clinicians committed to providing comprehensive care for individuals with bleeding and clotting disorders.

The program is designed to provide hands-on clinical training to licensed physicians not to mention prepare them for academic careers in bleeding and clotting disorders research.

Mentored training takes place at highly-qualified hemophilia and thrombophilia treatment centers located throughout the United States.

Funding is provided to cover costs associated with training promising physicians who show interest in devoting their careers to the care of patients with hemophilia and other bleeding or clotting disorders.

In the field of rare disorders, hemophilia has long been touted as a model for medical care delivery since the majority of patients benefit from treatment in comprehensive care centers.

However, this highly specialized care system has become increasingly fragile as a generation of HTC physicians either retire or choose to leave the field.

Such departures are accelerating as an ironic byproduct of the HTC success story : More and more patients receive prophylaxis and preventative care; more individuals are able to infuse themselves at home,  resulting in a reduction of patient-doctor contact hours.

This situation, coupled with a relatively stable to low number of hemophilia patients, has imperiled the profession as a viable full-time practice.

Other more systemic problems have included the lack of comprehensive training programs for bleeding disorder specialists and reduced institutional support for hemophilia clinical care and research.

Amidst these concerns, there also exists an inadequate system for meeting the needs of individuals affected by thrombosis and inherited thrombophilias.

One proposed solution for meeting these patients’ needs is to support the training of physicians who are skilled in the treatment of both conditions at specially-designated care centers.

NHF and Baxter firmly believe that this solution offers the means to further increase the number of quality treatment centers, the number of providers attracted to this field and also spur institutional support.

How to Apply for The NHF-Baxter Clinical Fellowship Program

Individual nominations for the NHF-Baxter Clinical Fellowship can only be made by institutions that have already applied and received approval to participate in the program.

Therefore, applying to the NHF-Baxter Clinical Fellowship Program is a two-tiered process. Please click on the links below for more detailed instructions and eligibility requirements on both applications:

Step One: Institutional Application – This application is intended for the medical director(s) and other senior faculty members / administrators affiliated with U.S. hemophilia and thrombophilia treatment centers not yet approved to participate in the NHF-Baxter Clinical Fellowship Program.

Only authorized institutions may subsequently nominate and train NHF-Baxter Clinical Fellows. If approved, authorization is granted for a period of five years.

Approved institutions must submit a re-application every five years, subject to review and approval, in order to continue their participation in the NHF-Baxter Clinical Fellows Program.

Step Two: Candidate Application – This application is intended for the medical director(s) and other senior faculty members / administrators from approved U.S. hemophilia and thrombophilia treatment centers to nominate qualified candidates as NHF-Baxter Clinical Fellows.

From among these candidates, two NHF-Baxter Clinical Fellows are selected each year and awarded up to $100,000 per year, for up to two years.

For complete application instructions for each of the two different applications for the NHF Clinical Fellowship, click on the relevant link above.

Application Deadline :  December 1, 2010

For further information, please contact :

Angelina Wang,
Director, Research and Medical Information,
116 West 32nd Street, 11th floor,
New York, NY 10001,
Phone: (212) 328-3727 or (800) 42-HANDI,
Fax: (212) 328-3799,
E-mail: awang-at-hemophilia.org.

Leave a Reply

Your email address will not be published. Required fields are marked *